empower pharmacy bpc-157 GLP-1s started as drugs to help patients with diabetes, but their success as a weight loss treatment helped boost their popularity., In 2022, drugmakers’ inability to keep up with demand for GLP-1s Shaun Noorian - Empower Pharmacy

While oral NAD+ supplements are widely available, many patients and providers prefer injectable formulations due to their enhanced bioavailability and more consistent results

Contamination with microbial endotoxins, incorrect peptide concentrations, and mislabeled compounds have been documented in independently tested peptide products

Our platform helps maximize your peptide investments

Personalised Approach We tailor every treatment to meet your specific needs and health goals

Gastric Emptying Modulation Dual Pathway Effect Both components contribute to delayed gastric emptying through complementary mechanisms[5]: GLP3 delays gastric emptying primarily through GLP-1R and glucagon receptor pathways Cagrilintide slows gastric transit through amylin and calcitonin receptor activation Combined effects produce more sustained gastric delay than single agents Prolonged nutrient exposure in the small intestine enhances incretin release This dual-pathway gastric slowing mechanism may explain enhanced satiety and reduced caloric intake observed in combination studies